Literature DB >> 17430696

Antibiotic pharmacodynamics and bacterial resistance: usefulness of in vitro models.

Stephen H Zinner1, Alexander Firsov.   

Abstract

Year:  2007        PMID： 17430696     DOI： 10.1007/s11908-007-0027-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  10 in total

1.  Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model.

Authors:  A A Firsov; V M Chernykh; S M Navashin
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Bacterial-population responses to drug-selective pressure: examination of garenoxacin's effect on Pseudomonas aeruginosa.

Authors:  Vincent H Tam; Arnold Louie; Mark R Deziel; Weiguo Liu; Robert Leary; George L Drusano
Journal:  J Infect Dis       Date:  2005-07-05       Impact factor: 5.226

3.  Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection.

Authors:  S L Preston; G L Drusano; A L Berman; C L Fowler; A T Chow; B Dornseif; V Reichl; J Natarajan; F A Wong; M Corrado
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

4.  Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.

Authors:  A Forrest; S Chodosh; M A Amantea; D A Collins; J J Schentag
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

5.  Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.

Authors:  Alexander A Firsov; Maria V Smirnova; Irene Yu Lubenko; Sergey N Vostrov; Yury A Portnoy; Stephen H Zinner
Journal:  J Antimicrob Chemother       Date:  2006-10-05       Impact factor: 5.790

Review 6.  Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies.

Authors:  X Zhao; K Drlica
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

7.  In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

Authors:  Alexander A Firsov; Sergey N Vostrov; Irene Y Lubenko; Karl Drlica; Yury A Portnoy; Stephen H Zinner
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

8.  Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.

Authors:  Jeffrey J Campion; Patrick J McNamara; Martin E Evans
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

9.  Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones.

Authors:  Alexander A Firsov; Irene Y Lubenko; Sergey N Vostrov; Yury A Portnoy; Stephen H Zinner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

10.  Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.

Authors:  Stephen H Zinner; Irene Yu Lubenko; Deborah Gilbert; Kelly Simmons; Xilin Zhao; Karl Drlica; Alexander A Firsov
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.